204 related articles for article (PubMed ID: 34888231)
1. Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram.
Cui H; Zhao D; Han P; Zhang X; Fan W; Zuo X; Wang P; Hu N; Kong H; Peng F; Wang Y; Tian J; Zhang L
Front Oncol; 2021; 11():718531. PubMed ID: 34888231
[TBL] [Abstract][Full Text] [Related]
2. Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.
Yan S; Wang W; Zhu B; Pan X; Wu X; Tao W
Cancer Manag Res; 2020; 12():8313-8323. PubMed ID: 32982426
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.
Qu F; Luo Y; Peng Y; Yu H; Sun L; Liu S; Zeng X
Front Immunol; 2023; 14():1335546. PubMed ID: 38274836
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer.
Qu F; Li Z; Lai S; Zhong X; Fu X; Huang X; Li Q; Liu S; Li H
Front Oncol; 2021; 11():681905. PubMed ID: 34692474
[TBL] [Abstract][Full Text] [Related]
6. A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.
Zhang F; Huang M; Zhou H; Chen K; Jin J; Wu Y; Ying L; Ding X; Su D; Zou D
Ann Surg Oncol; 2019 Nov; 26(12):3912-3919. PubMed ID: 31359285
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound Strain Elastography and Contrast-Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram Integrating Ki-67 and Ultrasound Features.
Liu Q; Tang L; Chen M
J Ultrasound Med; 2022 Sep; 41(9):2191-2201. PubMed ID: 34888900
[TBL] [Abstract][Full Text] [Related]
11. The Role of Nomogram Based on the Combination of Ultrasound Parameters and Clinical Indicators in the Degree of Pathological Remission of Breast Cancer.
Chen H; Qian H; Chen G; Zhu P; Sun C; Wu X; He Y
J Oncol; 2023; 2023():3077180. PubMed ID: 36844869
[TBL] [Abstract][Full Text] [Related]
12. A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy.
Ma R; Wei W; Ye H; Dang C; Li K; Yuan D
BMC Cancer; 2023 Mar; 23(1):245. PubMed ID: 36918796
[TBL] [Abstract][Full Text] [Related]
13. Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Dynamic Contrast-enhanced and Diffusion-weighted MRI.
Zhao R; Lu H; Li YB; Shao ZZ; Ma WJ; Liu PF
Acad Radiol; 2022 Jan; 29 Suppl 1():S155-S163. PubMed ID: 33593702
[TBL] [Abstract][Full Text] [Related]
14. [Comparing prediction performances of
Vincent L; Jankowski C; Arnould L; Coudert B; Rouzier R; Reyal F; Humbert O; Coutant C
Gynecol Obstet Fertil Senol; 2020 Sep; 48(9):679-686. PubMed ID: 32205278
[TBL] [Abstract][Full Text] [Related]
15. Prediction of pathological complete response of breast cancer patients who received neoadjuvant chemotherapy with a nomogram based on clinicopathologic variables, ultrasound, and MRI.
Zhang MQ; Liu XP; Du Y; Zha HL; Zha XM; Wang J; Liu XA; Wang SJ; Zou QG; Zhang JL; Li CY
Br J Radiol; 2024 Jan; 97(1153):228-236. PubMed ID: 38263817
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients.
Li Z; Tong Y; Chen X; Shen K
Front Oncol; 2022; 12():845823. PubMed ID: 35936729
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer.
Ochi T; Tsunoda H; Matsuda N; Nozaki F; Suzuki K; Takei H; Yamauchi H
Breast Cancer; 2021 Jul; 28(4):838-847. PubMed ID: 33560514
[TBL] [Abstract][Full Text] [Related]
18. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
19. Predicting pathological complete response after neoadjuvant chemotherapy: A nomogram combining clinical features and ultrasound semantics in patients with invasive breast cancer.
Wang KN; Meng YJ; Yu Y; Cai WR; Wang X; Cao XC; Ge J
Front Oncol; 2023; 13():1117538. PubMed ID: 37035201
[TBL] [Abstract][Full Text] [Related]
20. A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer.
Fang S; Xia W; Zhang H; Ni C; Wu J; Mo Q; Jiang M; Guan D; Yuan H; Chen W
Front Oncol; 2024; 14():1323226. PubMed ID: 38420013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
